Publication

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…

CertaraJune 2, 2026

On-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…

CertaraMay 26, 2026

Poster

Advancing In Vivo CAR-T with QSP

Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…

CertaraMay 12, 2026

Video

Certara IQ™ Demo

Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…

CertaraMay 12, 2026

Publication

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

QSP modeling reveals how anti-amyloid therapies impact tau biomarkers and cognitive outcomes in Alzheimer’s disease.

CertaraMay 4, 2026

Poster

Modeling CAR-T Outcomes in Multiple Myeloma

Learn how QSP modeling predicts CAR-T therapy outcomes, identifies patient-specific response drivers, and supports multi-antigen…

CertaraMay 4, 2026

Poster

Modeling T-cell Exhaustion in Immunotherapy

Discover how QSP modeling predicts T-cell exhaustion, relapse risk, and optimal dosing strategies for T-cell…

CertaraMay 4, 2026

Poster

Modeling Hematopoiesis in MDS and AML with QSP

Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…

CertaraMay 1, 2026

Poster

IO Simulator: A QSP Platform for Immuno-Oncology

This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…

CertaraApril 30, 2026

Blog

QSP at an Inflection Point: Scaling Impact

The QSP Summit at Certainty US 2026 brought together industry leaders to explore how Quantitative…

CertaraApril 29, 2026

Certara Products – Certara IQ

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Advancing In Vivo CAR-T with QSP

Certara IQ™ Demo

Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome

Modeling CAR-T Outcomes in Multiple Myeloma

Modeling T-cell Exhaustion in Immunotherapy

Modeling Hematopoiesis in MDS and AML with QSP

IO Simulator: A QSP Platform for Immuno-Oncology

QSP at an Inflection Point: Scaling Impact

Newsletter sign up

Quick links

Solutions

Contact